Product Information
MYCOPHENOLATE 200 MG/ML SUSP is a generic product labeled by VistaPharm, LLC, priced at $0.9816 per ML under NDC 66689030708. Its NADAC has been published 368 times since Aug 21, 2019.
FDA first approved this application on Feb 12, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Mycophenolate Mofetil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/mL
Manufacturer
VistaPharm, LLCNDC
66689030708
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MYCOPHENOLATE MOFETILApproval Type
Generic (ANDA)
FDA Application
ANDA210370FDA Approved
2/12/2019
TE Code
AB
On Market Since
2/15/2019
Pharmacological Classes
Price Statistics
The NADAC for MYCOPHENOLATE 200 MG/ML SUSP has been published 368 times since Aug 21, 2019, and over the history we have for it it has declined 84.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9816 per ML |
|---|---|
| All-time high | $6.3260 (Nov 13, 2019) |
| All-time low | $0.9324 (Jun 17, 2026) |
| 52-week high | $1.2816 |
| 52-week low | $0.9324 |
| Median price | $3.1208 |
| Average price | $3.4744 |
| Largest weekly change | -41.1% (Sep 21, 2022) |
| Weeks tracked | 368 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
VistaPharm, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mycophenolate Mofetil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antimetabolite Immunosuppressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MYCOPHENOLATE 200 MG/ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for MYCOPHENOLATE 200 MG/ML SUSP, manufactured by VistaPharm, LLC, is $0.9816 per ML (NDC 66689030708), effective Sep 30, 2026.
How has the price of MYCOPHENOLATE 200 MG/ML SUSP changed over time?
Over the history we have for it, the NADAC for MYCOPHENOLATE 200 MG/ML SUSP has declined 84.0%. It has been tracked across 368 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for MYCOPHENOLATE 200 MG/ML SUSP?
Since Aug 21, 2019, the NADAC for MYCOPHENOLATE 200 MG/ML SUSP has ranged from a low of $0.9324 (Jun 17, 2026) to a high of $6.3260 (Nov 13, 2019), with a median of $3.1208 per ML.
Are there cheaper alternatives to MYCOPHENOLATE 200 MG/ML SUSP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MYCOPHENOLATE 200 MG/ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures MYCOPHENOLATE 200 MG/ML SUSP?
MYCOPHENOLATE 200 MG/ML SUSP (NDC 66689030708) is labeled by VistaPharm, LLC, and CMS classifies it as a generic product.